Transepithelial Accelerated Corneal Collagen Cross-Linking: Two-Year Results.

Ana Maria CunhaTiago SardinhaLuís TorrãoRaúl MoreiraFernando Falcão-ReisJoão Pinheiro-Costa

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

Although some patients maintain disease progression, TE-ACXL seems to be a safe and effective treatment for keratoconus over the 2-year follow-up period. Studies with longer follow-up periods and larger patient cohorts are recommended.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
wound healing
optical coherence tomography
patient reported outcomes
combination therapy
replacement therapy